Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis

BACKGROUND: The COVID-19 causing coronavirus is an enveloped RNA virus that utilizes an enzyme RNA dependent RNA polymerase for its replication. Favipiravir (FVP) triphosphate, a purine nucleoside analog, inhibits that enzyme. We have conducted this systematic review and meta-analysis on efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Dhan Bahadur, Budhathoki, Pravash, Khadka, Sitaram, Shah, Prajwol Bikram, Pokharel, Nisheem, Rashmi, Prama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512218/
https://www.ncbi.nlm.nih.gov/pubmed/32972430
http://dx.doi.org/10.1186/s12985-020-01412-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512218/
https://www.ncbi.nlm.nih.gov/pubmed/32972430
http://dx.doi.org/10.1186/s12985-020-01412-z

Ejemplares similares